What is Acomplia 20mg?
- Generic Acomplia(Riomont) 20mg helps in treating long term weight loss and reduces the HDLs cholesterol which is responsible for putting on weight to the body however the consumption of Generic Acomplia raises the LDLs cholesterol which is good in treating the addiction of alcohol and drugs.
- Generic Acomplia 20mg is a safe and health friendly drug that treats the disease from the core. However Generic Acomplia works well on those who try to follow all the instructions suggested by doctors. It is suggested to all the people with obesity to do some physical exercise to support the medication from treating the disease.
- Acomplia 20mg acts by selectively blocking CB1 receptors found in the brain and in peripheral organs important in glucose and lipid (or fat) metabolism, including adipose tissue, the liver, gastrointestinal tract and muscle1.
- Acomplia 20mg switches off the same brain circuits that make people hungry when they smoke cannabis.
- CB1 receptor blockade with Acomplia acts to decrease the overactivity of the endocannabinoid system (EC system)2,3. The EC system is a recently characterised physiological system that includes receptors such as the CB1 receptor and it has been shown to play an important role in regulating body weight and in controlling energy balance, as well as glucose and lipid (or fat) metabolism.
What is Acomplia used for?
- Acomplia 20mg is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood.
- Sanofi argues that Acomplia can also prevent the risk of cardiovascular disease.
- Patients with large waist circumference (102 cm in men and 88 cm in women) will mostly benefit from taking the drug.
What were the results of Acomplia Clinical trial studies?
- In clinical studies, Acomplia has been shown to improve a wide array of cardiometabolic risk factors as well as promoting sustained weight loss4,5.
- Approximately half of the observed improvement in HDL-cholesterol, triglycerides and HbA1C (an indicator of blood sugar control) in patients who received Acomplia 20mg was beyond that expected from weight loss alone.